An overview of the biosimilars space Biosimilar developer Formycon puts the spotlight on the opportunities and challenges for the sector.
Samsung Biologics and European pharma company enter major manufacturing deal The global CDMO has entered into several high-value manufacturing deals this year.
FDA approves first-ever gene therapy to be directly administered to the brain PTC Therapeutics has received FDA approval for a gene therapy to treat AADC deficiency, a rare genetic disorder that impairs the normal function of neurons.
Serious adverse event causes problems for Neurogene’s Rett gene therapy A serious adverse event in the New York biotech’s phase 1/2 trial of its Rett syndrome gene therapy puts a question mark over the program.
Alentis raises $181 million to advance ADCs to the clinic The Series D financing will support the clinical development of two ADCs.
SEKISUI Diagnostics completes £15.7M expansion to boost biopharma manufacturing capacity New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma manufacturing at scale.
Promising early Parkinson’s immunotherapy results for AC Immune The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.
FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient.